Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
Immediate Angiography Could Preserve Function, Improve Outcomes in LVO Stroke
March 17th 2021An interim analysis of the ANGIOCAT trial suggests immediate angiography could help preserve function and improve outcomes in the treatment of patients with stroke caused by a large vessel occlusion compared to the current standard of performing a CT scan.
Read More
Beta-Blockers Could Cause Sleep Disturbances, But Not Linked to Depression
March 16th 2021A systematic review and meta-analysis of data from more than 280 studies is providing insight into the potential increase in risk of depression and other psychiatric adverse events associated with beta-blockers.
Read More
Comparing ADA vs. ACOG Approaches for Gestational Diabetes Screenings
March 16th 2021A trial of more than 20k women from investigators at Kaiser Permanente found there were no significant differences in outcomes among pregnant women undergoing gestational diabetes screenings using the ADA's 1-step approach versus the ACOG's 2-step approach.
Read More
Who is Responsible for Prescribing Weight Loss Medications to Obese Patients with Thomas Wadden, PhD
March 5th 2021After providing insight into the results of the STEP 1 and STEP 3 trials, Dr. Wadden discusses who he believes the responsibility for prescribing these medications will fall unto if semaglutide receives approval as a weight loss agent.
Read More
Risk Factor Prevalence Dangerously High, Poorly Controlled in Hispanic/Latino Adults
March 4th 2021An analysis of data from more than 16k Hispanic/Latino individuals indicates the prevalence of cardiovascular risk factors among those with a history of stroke/TIA was greater than previously thought and many are unaware of these risk factors.
Read More
Glycemic Index Linked to Increased Risk of Major Cardiovascular Events, Mortality
March 2nd 2021Data from the PURE study suggests an increased intake of poor quality carbohydrates was linked to an increased risk of major cardiovascular events and death in patients from 20 different countries.
Read More
Study Finds 5 Servings of Fruits and Vegetables Daily is "Ideal" for Health
March 2nd 2021An analysis of more than 2.8 million person-years of data suggests a mixture of 2 servings of fruit and 3 servings of vegetables per day was the "ideal" intake and provided the greatest amount of longevity.
Read More
STEP 1 and STEP 3 Results with Thomas Wadden, PhD
March 2nd 2021Published in late February, results of the STEP 1 and STEP 3 trial give clinicians insight into the effects of 2.4 mg subcutaneous semaglutide as an intervention for weight loss in overweight or obese patients ahead of a potential approval in June 2021.
Read More
Abnormal Sodium Levels Predict Risk of Mortality, Need for Ventilatory Support in COVID-19 Patients
February 26th 2021An analysis of nearly 500 patients hospitalized with COVID-19 from London suggests dysnatremia could help signal which patients were at an increased risk of complications, including death and need for respiratory support.
Read More
Web-Based Model Shows Promise for Predicting Stroke, Cardiac Events after Non-Cardiac Surgery
February 26th 2021A web-based model developed by a team at Thomas Jefferson University appeared to accurately predict risk of stroke and adverse cardiovascular events following non-cardiac surgery.
Read More
AHA Study Links 4 Major Conditions to More than 60% of COVID-19 Hospitalizations
February 25th 2021An analysis using data from the CDC, COVID-NET, and the COVID Tracking Project suggests nearly 2 out of 3 COVID-19 hospitalizations in the US were attributable to obesity, hypertension, diabetes, and heart failure.
Read More